Literature DB >> 16538043

Investigation of proteomic biomarkers in in vivo hepatotoxicity study of rat liver: toxicity differentiation in hepatotoxicants.

Toshinori Yamamoto1, Rie Kikkawa, Hiroshi Yamada, Ikuo Horii.   

Abstract

We investigated the overall protein expression profiles in the in vivo hepatotoxicity of rats induced by four well-recognized hepatotoxicants. Acetaminophen (APAP), amiodarone (AMD), tetracycline (TC) and carbon tetrachloride (CTC) were administered to male rats by gavages and the liver at 24 hr post-dosing was applied to the proteomic experiment. Blood biochemistry and histopathology were examined to identify specific changes related to the compounds given. Protein expression in the liver was investigated by 2-dimensional gel electrophoresis (2DE), and spots showing a significantly different expression in treated versus control group were excised from gels and identified by Q-Tof mass spectrometer. They were well characterized based on their functions related to the mechanisms of toxicity of the compounds. Among them, we focused on the 8 proteins that were affected by all 4 compounds examined. Proteins related to oxidative stress response such as carbonic anhydrase III (CA3) and 60kDa heat shock protein (HSP60), and energy metabolism such as adenylate kinase 4 (AK4) were found. Moreover, hierarchical clustering analysis using 2D-gel spots information revealed the possibility to differentiate the groups based on their toxicity levels such as severity of liver damage. These results suggested that assessing the effects of hepatotoxicants on protein expression is worth trying to screen candidate compounds at the developmental stage of drugs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16538043     DOI: 10.2131/jts.31.49

Source DB:  PubMed          Journal:  J Toxicol Sci        ISSN: 0388-1350            Impact factor:   2.196


  7 in total

1.  PGE2-regulated wnt signaling and N-acetylcysteine are synergistically hepatoprotective in zebrafish acetaminophen injury.

Authors:  Trista E North; I Ramesh Babu; Lea M Vedder; Allegra M Lord; John S Wishnok; Steven R Tannenbaum; Leonard I Zon; Wolfram Goessling
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-20       Impact factor: 11.205

2.  Enzymatically inactive adenylate kinase 4 interacts with mitochondrial ADP/ATP translocase.

Authors:  Rujuan Liu; Anna-Lena Ström; Jianjun Zhai; Jozsef Gal; Shilai Bao; Weimin Gong; Haining Zhu
Journal:  Int J Biochem Cell Biol       Date:  2008-12-14       Impact factor: 5.085

3.  Modulation of anti-cancer drug sensitivity through the regulation of mitochondrial activity by adenylate kinase 4.

Authors:  Koichi Fujisawa; Shuji Terai; Taro Takami; Naoki Yamamoto; Takahiro Yamasaki; Toshihiko Matsumoto; Kazuhito Yamaguchi; Yuji Owada; Hiroshi Nishina; Takafumi Noma; Isao Sakaida
Journal:  J Exp Clin Cancer Res       Date:  2016-03-16

4.  The miR-199a-3p regulates the radioresistance of esophageal cancer cells via targeting the AK4 gene.

Authors:  Chunbao Zang; Fangfang Zhao; Lei Hua; Youguang Pu
Journal:  Cancer Cell Int       Date:  2018-11-16       Impact factor: 5.722

5.  Adenylate kinase 4 modulates oxidative stress and stabilizes HIF-1α to drive lung adenocarcinoma metastasis.

Authors:  Yi-Hua Jan; Tsung-Ching Lai; Chih-Jen Yang; Yuan-Feng Lin; Ming-Shyan Huang; Michael Hsiao
Journal:  J Hematol Oncol       Date:  2019-01-29       Impact factor: 17.388

6.  Localization of adenylate kinase 4 in mouse tissues.

Authors:  Keiko Miyoshi; Yuki Akazawa; Taigo Horiguchi; Takafumi Noma
Journal:  Acta Histochem Cytochem       Date:  2009-04-07       Impact factor: 1.938

7.  MiR-199a-3p affects the multi-chemoresistance of osteosarcoma through targeting AK4.

Authors:  Wang Lei; Chen Yan; Jiang Ya; Dai Yong; Bian Yujun; Liu Kai
Journal:  BMC Cancer       Date:  2018-06-04       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.